Drug Discounts Pilot: Hospitals Apply for Rebate Model
Published Date: 8/1/2025
Notice
Summary
The 340B Rebate Model Pilot Program is a new, optional way for drug makers to help covered health providers get better drug prices. This program affects drug manufacturers and health centers that serve patients in need, aiming to keep medicine affordable. The application process is open now, and feedback is welcome, with possible updates coming later.
Analyzed Economic Effects
1 provisions identified: 1 benefits, 0 costs, 0 mixed.
Voluntary 340B Rebate Pilot Available Now
HHS/HRSA has opened a voluntary 340B Rebate Model Pilot Program that lets qualifying drug manufacturers apply to provide 340B ceiling prices on select drugs to covered entities (health centers). The application process is open now, HRSA is collecting public comments on the program and application, and the Notice is effective immediately as published.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Take It Personal
Get Your Personalized Policy View
Start a Free Government Policy Watch to see how policy affects your household, then upgrade to PRIA Full Coverage for year-round monitoring.
Already have an account? Sign in